Suppr超能文献

人干扰素制剂对唐氏综合征中淋巴细胞生成的影响。

Effect of human interferon preparations on lymphoblastogenesis in Down's syndrome.

作者信息

Cupples C G, Tan Y H

机构信息

Department of Medical Biochemistry and Pediatrics, University of Calgary, Alberta, Canada.

出版信息

Nature. 1977 May 12;267(5607):165-7. doi: 10.1038/267165a0.

Abstract

The best characterised properties of human interferon, its antiviral (AV) and cell multiplication inhibitory (CMI) activities, are controlled, in an unexplained manner, by genes on chromosomes 21 (refs 1-4; 14-16). Human and animal interferons have various immunosuppressive effects, among them the inhibition in vitro of DNA synthesis in activated lymphocytes. Using mitogen- and antigen-stimulated lymphocytes from normal subjects (disomic 21) and others with Down's syndrome (trisomic 21), we have found that DNA synthesis is inhibited to a greater degree in the latter by both fibroblastoid and leukocyte interferons. We suggest that this property is also regulated by genes on chromosome 21.

摘要

人类干扰素最具特征的特性,即其抗病毒(AV)和细胞增殖抑制(CMI)活性,以一种无法解释的方式,受21号染色体上的基因控制(参考文献1 - 4;14 - 16)。人和动物干扰素具有多种免疫抑制作用,其中包括在体外抑制活化淋巴细胞中的DNA合成。利用来自正常受试者(21号染色体二体)和其他唐氏综合征患者(21号染色体三体)的有丝分裂原和抗原刺激的淋巴细胞,我们发现,成纤维细胞样干扰素和白细胞干扰素对后者DNA合成的抑制程度更大。我们认为,这一特性也受21号染色体上的基因调控。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验